Transcranial Photobiomodulation in Anxiety Disorders
Recruiting · NCT07133893 · Interventional (participants receive a specific treatment) · Lead sponsor: Francisco Gonzalez-Lima, PhD
View the official record on ClinicalTrials.gov →Interventions studied
Attention bias assessment and modificationTranscranial photobiomodulation
What this trial is about
The investigators have previously shown that safe, non-invasive methods of brain stimulation such as the administration of transcranial infrared light can result in improvements to cognition and emotion. The investigators hypothesize that transcranial photobiomodulation (tPBM) can be used in conjunction with attention bias assessment and modification to reduce anxiety symptoms in individuals with sub-clinical anxiety.
Who can take part
Age range
18 Years to 100 Years
Sex
All (male and female)
Healthy volunteers
Yes - healthy volunteers may be accepted
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- 18 years of age and older
- State-Trait Anxiety Index (STAI) questionnaire score between 40-59 (indicates moderate sub-clinical anxiety)
- Patient Health Questionnaire (PHQ-9) score between 1-9 (indicates minimal to mild sub-clinical depression)
Exclusion criteria
- STAI score less than 40 or greater than 59
- PHQ-9 score greater than 9
- Medication instability (i.e., medication change within 6 weeks)
- Indicated suicidal ideation
- Currently receiving tPBM treatment
- Current pregnancy
Where it is running
1 location listed across 1 US state.
- The University of Texas at Austin - Austin, Texas, United States